Literature DB >> 17023218

Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study.

Patrick B Wood1, James C Patterson, John J Sunderland, Kerrie H Tainter, Michael F Glabus, David L Lilien.   

Abstract

UNLABELLED: Although the pathophysiology underlying the pain of fibromyalgia syndrome (FMS) remains unknown, a variety of clinical and investigational findings suggests a dysregulation of dopaminergic neurotransmission. We therefore investigated presynaptic dopaminergic function in 6 female FMS patients in comparison to 8 age- and gender-matched controls as assessed by positron emission tomography with 6-[(18)F]fluoro-L-DOPA as a tracer. Semiquantitative analysis revealed reductions in 6-[(18)F]fluoro-L-DOPA uptake in several brain regions, indicating a disruption of presynaptic dopamine activity wherein dopamine plays a putative role in natural analgesia. Although the small sample size makes these findings preliminary, it appears that FMS might be characterized by a disruption of dopaminergic neurotransmission. PERSPECTIVE: An association between FMS and reduced dopamine metabolism within the pain neuromatrix provides important insights into the pathophysiology of this mysterious disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023218     DOI: 10.1016/j.jpain.2006.05.014

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  76 in total

1.  The brain in chronic pain: clinical implications.

Authors:  A Vania Apkarian
Journal:  Pain Manag       Date:  2011-11-01

Review 2.  Variations in brain gray matter associated with chronic pain.

Authors:  Patrick B Wood
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

3.  Getting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans.

Authors:  Irene Tracey
Journal:  Nat Med       Date:  2010-10-14       Impact factor: 53.440

Review 4.  Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia.

Authors:  Andrew J Holman
Journal:  Curr Pain Headache Rep       Date:  2008-12

5.  The lateral prefrontal cortex mediates the hyperalgesic effects of negative cognitions in chronic pain patients.

Authors:  Marco L Loggia; Chantal Berna; Jieun Kim; Christine M Cahalan; Marc-Olivier Martel; Randy L Gollub; Ajay D Wasan; Vitaly Napadow; Robert R Edwards
Journal:  J Pain       Date:  2015-04-30       Impact factor: 5.820

6.  The effect of dopamine on pain-related neurons in the parafascicular nucleus of rats.

Authors:  H-R Gao; T-F Shi; C-X Yang; D Zhang; G-W Zhang; Y Zhang; R-S Jiao; H Zhang; M-Y Xu
Journal:  J Neural Transm (Vienna)       Date:  2010-04-01       Impact factor: 3.575

7.  Altered prefrontal correlates of monetary anticipation and outcome in chronic pain.

Authors:  Katherine T Martucci; Nicholas Borg; Kelly H MacNiven; Brian Knutson; Sean C Mackey
Journal:  Pain       Date:  2018-08       Impact factor: 6.961

8.  Striatal hypofunction as a neural correlate of mood alterations in chronic pain patients.

Authors:  Minhae Kim; Ishtiaq Mawla; Daniel S Albrecht; Roee Admon; Angel Torrado-Carvajal; Courtney Bergan; Ekaterina Protsenko; Poornima Kumar; Robert R Edwards; Atreyi Saha; Vitaly Napadow; Diego A Pizzagalli; Marco L Loggia
Journal:  Neuroimage       Date:  2020-02-15       Impact factor: 6.556

Review 9.  Towards a theory of chronic pain.

Authors:  A Vania Apkarian; Marwan N Baliki; Paul Y Geha
Journal:  Prog Neurobiol       Date:  2008-10-05       Impact factor: 11.685

Review 10.  Pathophysiology of fibromyalgia.

Authors:  Laurence A Bradley
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.